https://scholars.lib.ntu.edu.tw/handle/123456789/551903
標題: | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | 作者: | SHENG-KAI LIANG LI-TA KENG CHIA-HAO CHANG Wen, Yueh-Feng MENG-RUI LEE CHING-YAO YANG JANN-YUAN WANG JEN-CHUNG KO JIN-YUAN SHIH CHONG-JEN YU |
公開日期: | 2021 | 出版社: | Frontiers Media S.A. | 卷: | 10 | 起(迄)頁: | 590356 | 來源出版物: | Frontiers in Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099742333&doi=10.3389%2ffonc.2020.590356&partnerID=40&md5=b81f9bc6241932c9450909e70654077c https://scholars.lib.ntu.edu.tw/handle/123456789/551903 |
ISSN: | 2234-943X | DOI: | 10.3389/fonc.2020.590356 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。